Dayton student awarded scholarship from Gates Foundation
The scholarship is funded by the Bill and Melinda Gates Foundation and is a highly selective, nationally touted award.
Since 2000, the district has seen 19 students receive the award, now they can add one more to that total, as Paul Laurence Dunbar's own Simeon Akins earned the scholarship this year.
Centerville to feature Sinclair students art in new gallery
Akins is Paul Laurence Dunbar's Valedictorian and is known for his remarkable academic record and deep commitment to leadership, service and development.
'This honor is a testament to Simeon's hard work, dedication, and limitless potential. 'We are incredibly proud of him and are excited to see the amazing impact he will continue to make in the world,' said Dr. David Lawrence, superintendent of Dayton Public Schools.
With the grant, Akins will receive full financial coverage (tuition, fees, room, board, books, and transportation), mentoring and access to resources throughout his college career.
He plans to attend Belmont University this fall to major in either Computer Science or Music Production. He's also looking to minor in Art.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
02-07-2025
- Epoch Times
The Naturalist-Artists of the Victorian Era
'Victorians were in love with natural history,' in the introduction to an issue of Victorian Literature and Culture. The Victorian age was a time of booming scientific exploration and experimentation, yet this scientific interest didn't by any means wipe out a romantic and spiritual fascination with nature nor its aesthetic appreciation. These somewhat opposed tendencies—toward the systematic and rational on the one hand and the intuitive and aesthetic on the other—met and merged during the Victorian and Edwardian eras. As Gates put it, what the intellectual and artistic work of the day did 'was to build and reinforce powerful bridges: between science and art … between romanticism, with its expansive verbal tribute to nature, and Victorianism, with its adoration of concrete, detailed description.'
New York Post
20-06-2025
- New York Post
Bill Gates shares ‘next phase of Alzheimer's fight' as he speaks about his father's personal battle
Bill Gates is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. In an essay published this week on his blog at the Microsoft co-founder and tech billionaire, 69, reflected on the difficulty of spending another Father's Day without his dad, Bill Gates Sr. Advertisement The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. 'It was a brutal experience, watching my brilliant, loving father go downhill and disappear,' Gates wrote in the blog post. Today, motivated by his own experience with the common dementia, Gates — who serves as chair of the Gates Foundation — is committed to working toward a cure for the common dementia, which currently affects more than seven million Americans, or one in nine people over 65. In his blog, Gates expressed optimism about the 'massive progress' being made in the fight against Alzheimer's and other dementias. Advertisement Last year, Gates said he visited Indiana University's School of Medicine in Indianapolis to tour the labs where teams have been researching Alzheimer's biomarkers. 5 Bill Gates (left) is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. Brian Ach 'I also got the opportunity to look under the hood of new automated machines that will soon be running diagnostics around the world,' he wrote. 'It's an exciting time in a challenging space.' One of the biggest breakthroughs in Alzheimer's research, according to Gates, is blood-based diagnostic tests, which detect the ratio of amyloid plaques in the brain. (Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer's.) Advertisement 'I'm optimistic that these tests will be a game-changer,' Gates wrote. 5 The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. Bloomberg via Getty Images Last month, the U.S. Food and Drug Administration (FDA) approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. Traditionally, Gates noted, the primary path to Alzheimer's diagnosis was either a PET scan (medical imaging) or spinal tap (lumbar puncture), which were usually only performed when symptoms emerged. Advertisement The hope is that blood-based tests could do a better job of catching the disease early, decline begins. 5 Last month, the U.S. Food and Drug Administration approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. – 'We now know that the disease begins 15 to 20 years before you start to see any signs,' Gates wrote. 'A simple, accurate and easy-to-run blood test might one day make routine screening possible, identifying patients long before they experience cognitive decline,' he stated. Gates said he is often asked, 'What is the point of getting diagnosed if I can't do anything about it?' Start and end your day informed with our newsletters Morning Report and Evening Update: Your source for today's top stories Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters To that end, he expressed his optimism for the future of Alzheimer's treatments, noting that two drugs — Lecanemab (Leqembi) and Donanemab (Kisunla) — have gained FDA approval. 'Both have proven to modestly slow down the progression of the disease, but what I'm really excited about is their potential when paired with an early diagnostic,' Gates noted. Advertisement He said he is also hopeful that the blood tests will help speed up the process of enrolling patients in clinical trials for new Alzheimer's drugs. 5 The hope is that blood-based tests could do a better job of catching the disease early, decline begins. Monkey Business – To accomplish this, Gates is calling for increased funding for research, which often comes from federal grants. 'This is the moment to spend more money on research, not less,' he wrote, also stating that 'the quest to stop Alzheimer's has never had more momentum.' Advertisement 'There is still a huge amount of work to be done — like deepening our understanding of the disease's pathology and developing even better diagnostics,' Gates went on. 5 Microsoft Chairman Bill Gates, his wife Melinda, far left, his father Bill Gates Sr., and his step-mother Mimi Gates pose for a photo in 2007. AP Gates pointed out that when his father had Alzheimer's, it was considered a 'death sentence,' but that is starting to change. Advertisement 'I am blown away by how much we have learned about Alzheimer's over the last couple of years,' he wrote. 'I cannot help but be filled with a sense of hope when I think of all the progress being made on Alzheimer's, even with so many challenges happening around the world. We are closer than ever before to a world where no one has to watch someone they love suffer from this awful disease.'
Yahoo
10-06-2025
- Yahoo
UD professor earns $400K+ for new brain study
DAYTON, Ohio (WDTN) — A local professor is receiving quite a boon for their research. University of Dayton biology professor Pothitos M. Pitychoutis, is receiving a grant of $413,681 to study a potential catalyst for conditions such as autism, schizophrenia and ADHD. The purpose behind the study is to find more effective and safer treatments for these conditions. 'Overall, gaining insights into the regulation of calcium-cycling processes in the brain may pave the way for developing new, safer and more effective drug therapies for the treatment of these debilitating and costly brain disorders,' Pitychoutis said. Pitychoutis' study will see a closer look at phospholamban, the calcium-handling protein and its impact in the part of the brain that manages sleep, attention and how we process stimuli around us. The grant will help with Pitychoutis' efforts as well as opportunities available for UD students. 'Working on this project will help prepare some of our talented students to pursue postgraduate studies in neuroscience and follow careers in industry and academia, as well as in biomedical and health-related professions,' Pitychoutis said. While the university currently hosts a neuroscience minor, the program will expand to serve as a major for students beginning this fall. For more information on the study and the grant award to Pitychoutis, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
